REVENUES

9 Months Ended

Sep. 30, 2023

REVENUES

REVENUES

NOTE 4 – REVENUES

The following table summarizes the Company’s disaggregation of revenues:

	Three Months Ended September 30,				Nine Months Ended September 30,
(U.S. dollars in thousands)	2023		2022		2023		2022
Pfizer	$	2,304	$	4,541	$	7,972	$	11,279
Brazil	$	2,320	$	1,708	$	5,120	$	7,162
Chiesi	$	5,544	$	2,563	$	17,217	$	2,781
Total revenues from selling goods	$	10,168	$	8,812	$	30,309	$	21,222
Revenues from license and R&D services	$	177	$	5,371	$	24,699	$	17,799